Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

(ANTX) logo

About (ANTX) Stock (NYSE:ANTX)

Key Stats

Today's Range
$1.07
$1.33
50-Day Range
N/A
52-Week Range
$47.02
$64.78
Volume
5.55 million shs
Average Volume
507,363 shs
Market Capitalization
$38.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.67
Consensus Rating
Hold

Company Overview

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

(ANTX) Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
56th Percentile Overall Score

ANTX MarketRank™: 

(ANTX) scored higher than 56% of companies evaluated by MarketBeat, and ranked 515th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    (ANTX) has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    (ANTX) has only been the subject of 2 research reports in the past 90 days.

  • Read more about (ANTX)'s stock forecast and price target.
  • Earnings Growth

    Earnings for (ANTX) are expected to grow in the coming year, from ($1.68) to ($0.96) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of (ANTX) is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of (ANTX) is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    (ANTX) has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ANTX.
  • Dividend Yield

    (ANTX) does not currently pay a dividend.

  • Dividend Growth

    (ANTX) does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ANTX.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for (ANTX) this week, compared to 0 articles on an average week.
  • Search Interest

    2 people have searched for ANTX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, (ANTX) insiders have bought more of their company's stock than they have sold. Specifically, they have bought $70,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    20.79% of the stock of (ANTX) is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    90.47% of the stock of (ANTX) is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about (ANTX)'s insider trading history.
Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

ANTX Stock News Headlines

AN2 Therapeutics downgraded to Hold from Buy at TD Cowen
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
TD Cowen downgrades AN2 Therapeutics, Inc. (ANTX) to a Hold
3 Penny Stocks To Buy With Just $750
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

(ANTX) (NYSE:ANTX) issued its earnings results on Tuesday, August, 13th. The company reported ($0.48) EPS for the quarter, topping analysts' consensus estimates of ($0.59) by $0.11.

(ANTX) (ANTX) raised $69 million in an initial public offering on Friday, March 25th 2022. The company issued 4,600,000 shares at a price of $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Broadcom (AVGO), NVIDIA (NVDA), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/13/2024
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Previous Symbol
NASDAQ:ANTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.67
High Stock Price Target
$5.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+105.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

Net Income
$-64,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.93 per share

Miscellaneous

Free Float
23,667,000
Market Cap
$38.84 million
Optionable
Not Optionable
Beta
-0.22
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NYSE:ANTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners